Baker Brothers Advisors - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 56 filers reported holding VINCERX PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q2 2023$293,253
+16.8%
225,579
-6.5%
0.00%
+100.0%
Q1 2023$251,034
+2.0%
241,3790.0%0.00%0.0%
Q4 2022$246,207
-26.1%
241,3790.0%0.00%
-50.0%
Q3 2022$333,000
+4.4%
241,3790.0%0.00%0.0%
Q2 2022$319,000
-67.0%
241,3790.0%0.00%
-66.7%
Q1 2022$966,000
-60.7%
241,3790.0%0.01%
-50.0%
Q4 2021$2,460,000
-37.0%
241,3790.0%0.01%
-29.4%
Q3 2021$3,903,000241,3790.02%
Other shareholders
VINCERX PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,658,199$2,189,0000.84%
Affinity Asset Advisors, LLC 1,374,098$1,814,0000.76%
SABBY MANAGEMENT, LLC 500,559$661,0000.45%
TANG CAPITAL MANAGEMENT LLC 1,030,634$1,360,0000.21%
Rubric Capital Management LP 2,107,000$2,781,0000.15%
Long Focus Capital Management, LLC 980,000$1,294,0000.14%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$508,0000.09%
Clearline Capital LP 452,184$597,0000.08%
Sio Capital Management, LLC 102,049$135,0000.05%
Rock Springs Capital Management LP 814,194$1,075,0000.03%
View complete list of VINCERX PHARMA INC shareholders